Dobrin, Anton http://orcid.org/0000-0002-9751-0677
Lindenbergh, Pieter L.
Shi, Yuzhe http://orcid.org/0009-0009-8483-0418
Perica, Karlo
Xie, Hongyao
Jain, Nayan
Chow, Andrew http://orcid.org/0000-0003-1151-2450
Wolchok, Jedd D. http://orcid.org/0000-0001-6718-2222
Merghoub, Taha http://orcid.org/0000-0002-1518-5111
Sadelain, Michel http://orcid.org/0000-0002-9031-8025
Hamieh, Mohamad
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA08748)
Lake Road Foundation Lymphoma and Leukemia Society The Pasteur-Weizmann/Servier award The Leopold Griffuel award
Gouvernement du Canada | Canadian Institutes of Health Research (CIHR-IRSC:0207000741)
Article History
Received: 20 December 2022
Accepted: 12 February 2024
First Online: 19 March 2024
Competing interests
: Memorial Sloan Kettering has submitted a patent application based, in part, on results presented in this manuscript (A.D., M.H. and M.S. are listed among the inventors). M.S. reports research funding from Fate Therapeutics, Takeda Pharmaceuticals, Atara Biotherapeutics and Mnemo Therapeutics. The other authors declare no competing interests.